Home/Filings/4/0001213900-22-006175
4//SEC Filing

BRIGHAM MICHAEL F 4

Accession 0001213900-22-006175

CIK 0000811641other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:58 PM ET

Size

5.6 KB

Accession

0001213900-22-006175

Insider Transaction Report

Form 4
Period: 2022-01-31
BRIGHAM MICHAEL F
DirectorPresident & CEO
Transactions
  • Award

    Incentive Stock Options (Right to buy)

    2022-01-31$8.15/sh+1,000$8,1501,000 total
    Exercise: $8.15From: 2025-01-31Exp: 2032-01-31Common Stock (1,000 underlying)
Footnotes (1)
  • [F1]This stock option grant is made subject to the reservation of more shares for the Company's 2017 Stock Option Plan by vote of stockholders at the 2022 Annual Meeting of the Company.

Issuer

IMMUCELL CORP /DE/

CIK 0000811641

Entity typeother

Related Parties

1
  • filerCIK 0001136544

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:58 PM ET
Size
5.6 KB